This inventor holds 1 USPTO granted patent and 7 published patent applications. Top assignee: Kalypsys, Inc.. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Innovations of Clay Beauregard
Introduction
Clay Beauregard is an accomplished inventor based in Fort Worth, Texas. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that target inflammatory diseases.
Latest Patents
Beauregard holds a patent for "Heteroarylalkoxy-substituted quinolone inhibitors of PDE4." This invention relates to compounds and methods that may be useful as inhibitors of phosphodiesterase 4 (PDE4) for the treatment or prevention of inflammatory diseases and other conditions involving elevated levels of cytokines and proinflammatory mediators.
Career Highlights
Beauregard is associated with Kalypsys, Inc., where he has been instrumental in advancing research initiatives. His work focuses on innovative solutions to complex medical challenges, showcasing his dedication to improving health outcomes.
Collaborations
He has collaborated with notable colleagues, including Steven P. Govek and Daniel A. Gamache, contributing to a dynamic research environment that fosters innovation.
Conclusion
Clay Beauregard's contributions to the field of pharmaceutical inventions highlight his commitment to addressing critical health issues through innovative research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile